分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Interleukin-1 receptor-associated kinase 3 downregulation in peripheral blood mononuclear cells attenuates immunosuppression in sepsis

Qin Xia, Yupin Zhou, Xi Wang, Shukun Fu

Journal:Experimental and Therapeutic Medicine

IF:1.26

DOI:10.3892/etm.2017.5549

PMID:29434744

Published:2017-11-23

research field:免疫学传染病学重症医学

Abstract

Sepsis is the leading cause of mortality in intensive care units due to complex inflammatory immune responses and immunosuppression. Recent studies have indicated that the negative regulator of toll like receptors, interleukin‑1 receptor‑associated kinase 3 (IRAK‑3/IRAK‑M), serves an important role in immunosuppression during sepsis. In the current study, a cecal ligation puncture model was established in mice using lipopolysaccharide secondary challenge to simulate immunosuppression in sepsis. Peripheral blood mononuclear cells (PBMCs) from this model were then used to evaluate the expression and function of IRAK‑M. The results demonstrated that silencing of IRAK‑M expression in PBMCs from immunosuppressed mice partially restored the production of pro‑inflammatory cytokines. By introducing PBMCs transfected with small‑interfering RNA targeting IRAK‑M into septic immunosuppressed mice, the survival rate was improved with an increase in splenic CD4+ and CD8+ T cells and a decrease in T cell apoptosis. In conclusion, downregulation of IRAK‑M reversed the effects of sepsis on the production of inflammatory cytokines in PBMCs, and improved the survival of septic immunosuppressed mice. These results provide a basis for future studies investigating the immunological mechanisms underlying immune suppression in sepsis.

本文使用的Yeasen产品

购物车
客服
转染试用